VRDN

23.29

1.97% 0.45

Dopo l'orario di chiusura: 22.82 -0.47 -2.02%

Viridian Therapeutics Inc (VRDN)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$22.84

Aprire:

$22.85

Volume 24 ore:

495.41K

Relative Volume:

0.37

Capitalizzazione di mercato:

$1.73B

Reddito:

$314.00K

Utile/perdita netta:

$-237.73M

Rapporto P/E:

-4.7823

EPS:

-4.87

Flusso di cassa netto:

$-185.07M

1 W Prestazione:

+2.42%

1M Prestazione:

-2.63%

6M Prestazione:

+51.23%

1 anno Prestazione:

+53.32%

Intervallo 1D:

$22.31

$23.34

Intervallo di 1 settimana:

$21.53

$23.34

Portata 52W:

$11.40

$25.39

Viridian Therapeutics Inc Stock (VRDN) Company Profile

Nome

Viridian Therapeutics Inc

Settore

Healthcare (1182)

Industria

Biotechnology (671)

Telefono

617.272.4600

Indirizzo

221 CRESCENT STREET, WALTHAM

Dipendente

Cinguettio

Prossima data di guadagno

2024-11-11

Ultimi documenti SEC

VRDN's Discussions on Twitter

Viridian Therapeutics Inc Stock (VRDN) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2023-06-14	Iniziato	BTIG Research	Buy
2023-06-14	Ripresa	Credit Suisse	Outperform
2023-05-30	Iniziato	RBC Capital Mkts	Outperform
2023-04-17	Iniziato	Wells Fargo	Overweight
2023-03-30	Iniziato	Stifel	Buy
2022-12-19	Iniziato	Cowen	Outperform
2022-12-19	Iniziato	Needham	Buy
2022-12-16	Iniziato	Credit Suisse	Outperform
2022-12-01	Iniziato	H.C. Wainwright	Buy
2022-06-23	Iniziato	B. Riley Securities	Buy
2021-11-18	Iniziato	SVB Leerink	Outperform
2021-10-12	Iniziato	Evercore ISI	Outperform
2021-01-25	Iniziato	Ladenburg Thalmann	Buy

Mostra tutto

Viridian Therapeutics Inc Borsa (VRDN) Ultime notizie

04:01 AM

Viridian Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire

04:01 AM

02:36 AM

(VRDN) Long Term Investment Analysis - Stock Traders Daily

02:36 AM

Oct 31, 2024

Viridian Therapeutics Insiders Added US$616.3k Of Stock To Their Holdings - Yahoo Finance

Oct 31, 2024

Oct 28, 2024

Analyst Expectations For Viridian Therapeutics's Future - Fidelity Investments

Oct 28, 2024

Needham & Company LLC Reaffirms Buy Rating for Viridian Therapeutics (NASDAQ:VRDN) - MarketBeat

Oct 28, 2024

Oct 27, 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Position Boosted by Novo Holdings A S - MarketBeat

Oct 27, 2024

Oct 25, 2024

How To Trade (VRDN) - Stock Traders Daily

Oct 25, 2024

Oct 23, 2024

VRDN Factor-Based Stock Analysis - Nasdaq

Oct 23, 2024

Viridian Therapeutics' Superior Prospects Make It A Buy (NASDAQ:VRDN) - Seeking Alpha

Oct 23, 2024

Viridian Therapeutics (VRDN): A Small-Cap Biotech with Promising Clinical Results - Insider Monkey

Oct 23, 2024

Oct 22, 2024

8 Best Small-Cap Growth Stocks to Buy According to Analysts - Insider Monkey

Oct 22, 2024

Oct 21, 2024

Viridian Therapeutics, Inc. (NASDAQ:VRDN) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 21, 2024

Oct 19, 2024

SG Americas Securities LLC Has $374,000 Stock Position in Viridian Therapeutics, Inc. (NASDAQ:VRDN) - MarketBeat

Oct 19, 2024

Oct 18, 2024

State Street Corp's Strategic Reduction in Viridian Therapeutics Inc - Yahoo Finance

Oct 18, 2024

Viridian Therapeutics (NASDAQ:VRDN) Hits New 52-Week HighTime to Buy? - MarketBeat

Oct 18, 2024

Oct 16, 2024